top of page
MICHAEL KLEIN PhD
CONSULTANT
Q&A with Michael Klein, Ph.D.: Combating Misuse and Abuse of Prescription Drugs
GUIDANCE FOR INDUSTRY – ASSESSMENT OF ABUSE POTENTIAL OF DRUGS, JANUARY 19, 2017
GUIDANCE FOR INDUSTRY – ABUSE-DETERRENT OPIOIDS — EVALUATION AND LABELING, APRIL 2015
​
Title 21 United States Code (USC) Controlled Substances Act, SUBCHAPTER I — CONTROL AND ENFORCEMENT,
Part B — Authority to Control; Standards and Schedules:
​
​
bottom of page